IBD Medication Guide

Ad
Adalimumab
Ad

Adalimumab

Brand Name(s)

Humira®

Drug Class

Biologics

How taken

Injection under the skin (subcutaneous)

Used for

Moderate to severe Crohn’s disease and ulcerative colitis

Recommendations for Pregnancy

Low risk

Recommendations for Lactation

Limited human data: probably compatible

Medication indication

Reduces signs and symptoms and induces and maintains clinical response in adults and children with moderately to severely active Crohn’s disease and ulcerative colitis who have had an inadequate response to conventional therapy.

Indicated for pediatric use

Yes

Most common side effects

Common side-effects include injection site reactions such as redness, rash, swelling, itching, pain, or bruising; upper respiratory infections (including sinus infections); headaches, rash, nausea. Rare side effects include lupus-like syndrome.

Other

There have been reports of serious infections associated with adalimumab, including tuberculosis (TB) and other infections such as viruses, fungi, and other bacteria that have spread throughout the body. On rare occasions certain types of cancer, including lymphoma, have been reported.

To see the full prescribing information for this medication, click here.

Learn more about biologics

Scroll right by clicking & dragging with your cursor or swiping with your finger.